NCT06764771 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06764771
Title	A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Bristol-Myers Squibb
Indications	pancreatic ductal adenocarcinoma Advanced Solid Tumor colorectal cancer ovarian clear cell carcinoma lung non-small cell carcinoma clear cell renal cell carcinoma
Therapies	Adagrasib + BMS-986488 + Cetuximab BMS-986488 + Nivolumab BMS-986488 Adagrasib + BMS-986488
Age Groups:	senior \| adult
Covered Countries	USA \| CAN \| AUS

Facility	City	State	Zip	Country	Details
Local Institution - 0021	Hackensack	New Jersey	07601	United States	Details
Local Institution - 0020	Allentown	Pennsylvania	18103	United States	Details
Local Institution - 0024	Germantown	Tennessee	38138	United States	Details
Local Institution - 0031	Brisbane	Queensland	4029	Australia	Details
Local Institution - 0032	Vancouver	British Columbia	V5Z 4E6	Canada	Details
Local Institution - 0015	Montreal	Quebec	H2X 0A9	Canada	Details
Local Institution - 0016	Québec	Quebec	G1J 1Z4	Canada	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06764771Clinical Trial Detail